Prashanth R.J. Vas*, Erika Vainieri and Natasha Patel Pages 1080 - 1092 ( 13 )
The care of the individual with diabetic foot disease (DFD) represents a significant challenge. In addition to the primary foot pathology, individuals with DFD are frequently compromised by multiple co-existent medical complications. Successful management of DFD, therefore requires simultaneous addressal of these issues alongside high-quality foot care. We explore the pharmacological treatments in DFD with an emphasis on the emerging putative technologies centred on addressing the pathobiology of wound healing but also discuss developments in infection control, Charcot neuroarthropathy, cardiovascular and diabetes care. Many of these will have a significant impact on future treatment paradigms and how we amalgamate these novel technologies may help shape the standard of care in DFD hereafter. However, there is a need for better quality of evidence and cost-effectiveness data prior to widespread adoption into routine care is considered.
Diabetic foot disease, diabetic foot ulcer, wound healing, cardiovascular risk, glycaemic control, charcot foot, pharmacotherapy in diabetic foot.
King’s College Hospital NHS Foundation Trust, London, King’s College Hospital NHS Foundation Trust, London, Guys and St Thomas’ Hospitals NHS Foundation Trust, London